Otsuka Holdings
4578.T
#709
Rank
NZ$49.41 B
Marketcap
$91.74
Share price
-4.17%
Change (1 day)
46.37%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Market capitalization of Otsuka Holdings (4578.T)

Market cap: NZ$49.41 Billion

As of January 2025 Otsuka Holdings has a market cap of NZ$49.41 Billion. This makes Otsuka Holdings the world's 709th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Otsuka Holdings from 2010 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$49.41 B-5.66%
2024NZ$52.38 B62.62%
2023NZ$32.21 B17.14%
2022NZ$27.50 B-4.41%
2021NZ$28.76 B-10.66%
2020NZ$32.20 B-10.83%
2019NZ$36.11 B9.78%
2018NZ$32.89 B-1.64%
2017NZ$33.44 B-2.4%
2016NZ$34.26 B20.76%
2015NZ$28.37 B35.52%
2014NZ$20.93 B7.93%
2013NZ$19.39 B1.03%
2012NZ$19.20 B-3.6%
2011NZ$19.91 B31.36%
2010NZ$15.16 B

End of Day market cap according to different sources

On Jan 9th, 2025 the market cap of Otsuka Holdings was reported to be:

NZ$51.56 Billion
by Yahoo Finance info icon info icon
NZ$51.56 Billion
by CompaniesMarketCap info icon info icon